Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study
- PMID: 23175513
- DOI: 10.1177/0269216312464408
Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study
Abstract
Background: Neuropathic pain causes greater pain intensity and worse quality of life than nociceptive pain. There are no published data that confirm this in the cancer population.
Aim: We hypothesised that patients with neuropathic cancer pain had more intense pain, experienced greater suffering and were treated with more analgesics than those with nociceptive cancer pain, and a neuropathic pain screening tool, painDETECT, would perform as well in those with cancer pain as is reported in those with non-cancer pain.
Design: The data were obtained from an international cross-sectional observational study.
Setting/participants: A total of 1051 patients from inpatients and outpatients, with incurable cancer completed a computerised assessment on symptoms, function and quality of life. In all, 17 centres within eight countries participated. Medical data were recorded by physicians. Pain type was a clinical diagnosis recorded on the Edmonton Classification System for Cancer Pain.
Results: Of the patients, 670 had pain: 534 with nociceptive pain, 113 with neuropathic pain and 23 were unclassified. Patients with neuropathic cancer pain were significantly more likely to be receiving oncological treatment, strong opioids and adjuvant analgesia and have a reduced performance status. They reported worse physical, cognitive and social function. Sensitivity and specificity of painDETECT for identifying neuropathic cancer pain was less accurate than when used in non-cancer populations.
Conclusions: Neuropathic cancer pain is associated with a negative impact on daily living and greater analgesic requirements than nociceptive cancer pain. Validated assessment methods are needed to enable early identification of neuropathic cancer pain, leading to more appropriate treatment and reduced burden on patients.
Keywords: Neuralgia; analgesics; neoplasms; pain; pain measurement; palliative care.
Similar articles
-
Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.Pain Pract. 2017 Jan;17(1):88-98. doi: 10.1111/papr.12422. Epub 2016 Mar 15. Pain Pract. 2017. PMID: 26991802
-
Neuropathic pain in children with cancer.J Pediatr Oncol Nurs. 2004 Nov-Dec;21(6):350-7. doi: 10.1177/1043454204270251. J Pediatr Oncol Nurs. 2004. PMID: 15475472 Review.
-
Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities.Pain Pract. 2016 Apr;16(4):413-21. doi: 10.1111/papr.12291. Epub 2015 Apr 10. Pain Pract. 2016. PMID: 25857631
-
Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life.Cancer Nurs. 2013 May-Jun;36(3):229-35. doi: 10.1097/NCC.0b013e3182664c95. Cancer Nurs. 2013. PMID: 22964871
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
-
The Use of Low-Dose Methadone as Add-On to Ongoing Opioid Treatment in Palliative Cancer Care-An Underrated Treatment?Life (Basel). 2022 May 3;12(5):679. doi: 10.3390/life12050679. Life (Basel). 2022. PMID: 35629347 Free PMC article. Review.
-
Cancer-Related Neuropathic Pain.Cancers (Basel). 2019 Mar 16;11(3):373. doi: 10.3390/cancers11030373. Cancers (Basel). 2019. PMID: 30884837 Free PMC article. Review.
-
Neuropathic cancer pain: prevalence, pathophysiology, and management.Korean J Intern Med. 2018 Nov;33(6):1058-1069. doi: 10.3904/kjim.2018.162. Epub 2018 Jun 25. Korean J Intern Med. 2018. PMID: 29929349 Free PMC article. Review.
-
Neuropathic pain in patients with sickle cell disease.Pediatr Blood Cancer. 2014 Mar;61(3):512-7. doi: 10.1002/pbc.24838. Epub 2013 Oct 26. Pediatr Blood Cancer. 2014. PMID: 24167104 Free PMC article.
-
Tapentadol in neuropathic pain cancer patients: a prospective open label study.Neurol Sci. 2017 Oct;38(10):1747-1752. doi: 10.1007/s10072-017-3035-1. Epub 2017 Jul 11. Neurol Sci. 2017. PMID: 28699105
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources